Fresenius Medical Care 

$23.45
337
+$0.43+1.87% 今天

統計

當日最高
23.71
當日最低
23.43
52週高點
28.96
52週低點
20.02
成交量
663,457
平均成交量
713,361
市值
0
本益比
12.18
股息殖利率
3.72%
股息
0.87

即將到來

股息

3.72%股息殖利率
Jun 26
$0.87
Jun 25
$0.81
Jun 24
$0.64
Jun 23
$0.60
May 22
$0.71
10年成長
6.79%
5年成長
1.25%
3年成長
12.95%
1年成長
6.95%

財報

4Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
0.79
0.96
1.12
1.29
預期EPS
1.2194702472
實際EPS
不適用

財務

2.79%利潤率
有盈利
2019
2020
2021
2022
2023
2024
40.79B營收
1.14B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 FMS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.
Show more...
執行長
Ms. Helen Giza
員工
112035
國家
美國
ISIN
US3580291066

上市

0 Comments

分享你的想法

FAQ

Fresenius Medical Care 今天的股價是多少?
FMS 目前價格為 $23.45 USD,過去 24 小時上漲了 +1.87%。在圖表上更密切關注 Fresenius Medical Care 股價表現。
Fresenius Medical Care 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Fresenius Medical Care 的股票以代號 FMS 進行交易。
Fresenius Medical Care 的股價在上漲嗎?
FMS 股票較上週上漲 +7.62%,本月上漲 +8.56%,但過去一年 Fresenius Medical Care 下跌 -18.04%。
Fresenius Medical Care 下一次財報日期是什麼時候?
Fresenius Medical Care 將於 August 04, 2026 公布下一次財報。
Fresenius Medical Care 上一季度的財報如何?
FMS 上一季度的財報為每股 1.05 USD,預估為 1.17 USD,帶來 -10.06% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Fresenius Medical Care 去年的營收是多少?
Fresenius Medical Care 去年的營收為 40.79BUSD。
Fresenius Medical Care 去年的淨利是多少?
FMS 去年的淨收益為 1.14BUSD。
Fresenius Medical Care 會發放股息嗎?
是的,FMS 的股息每 年度 發放一次。每股最新股息為 0.87 USD。截至今日,股息殖利率(FWD)% 為 3.72%。
Fresenius Medical Care 有多少名員工?
截至 June 15, 2026,公司共有 112,035 名員工。
Fresenius Medical Care 位於哪個產業?
Fresenius Medical Care從事於Health & Wellness產業。
Fresenius Medical Care 何時完成拆股?
Fresenius Medical Care 上次拆股發生於 December 04, 2012,比例為 2:1。
Fresenius Medical Care 的總部在哪裡?
Fresenius Medical Care 的總部位於 美國 的 Bad Homburg。